Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors
Michele Bartoletti, Lucia Musacchio, Gaia Giannone, Valentina Tuninetti, Alice Bergamini, Giovanni Scambia, Domenica Lorusso, Giorgio Valabrega, Giorgia Mangili, Fabio Puglisi, S Pignata
Topics & Concepts
MedicineOvarian cancerHistologyPoly ADP ribose polymeraseCancer researchOncologyPARP inhibitorInternal medicineCancerGeneGeneticsPolymeraseBiologyPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentToxin Mechanisms and Immunotoxins